Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000
Samaritan Pharmaceuticals has received a notice that a European Patent has been granted to Samaritan's SP-1000 (Cholesterol Recognition Sequence) drug for the treatment of cardiovascular disease. - January 09, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board
Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals
Schering Plough to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Jianhua Chao, Principal Scientist of Discovery Chemical Research at Schering-Plough will give a presentation entitled “Potent, Orally Active CXCR2-CXCR1 Antagonists as Anti-inflammatory Therapy” at GTCbio’s 6th Cytokines and Inflammation. (January 28-29, 2008, Orlando,... - January 07, 2008 - GTCbio
FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study
The U.S. Food and Drug Administration (FDA) has completed its regulatory review of Samaritan's IND (Investigational New Drug) application for Cushing's syndrome SP-6300 and declared it has not identified any deficiencies in its IND filing. Accordingly, Samaritan can proceed with its proposed Phase II clinical study of Cushing's syndrome SP-6300's efficacy in patients experiencing Hypercortisolism. - January 04, 2008 - Samaritan Pharmaceuticals
Matrix Sample Tracking Software is Chosen by Leading Pharmaceutical Company
Matrix Sample Tracking software has been chosen by the Research Division of a major, multi-national pharmaceutical company. It is being implemented at sites in America, Europe and Asia to track samples and slides through the entire pre-clinical, Safety Assessment Division. Peter Mansfield,... - January 04, 2008 - Autoscribe Ltd.
Samaritan Expands Revenue Opportunities with Marketing Authorization Approval for HIV Drug Amphocil in Cyprus
Samaritan Pharmaceuticals, Inc. is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification, from the Cyprus Ministry of Health, that its marketing authorization for HIV fungus drug Amphocil has been approved in Cyprus. The Cyprus Ministry of Health... - January 03, 2008 - Samaritan Pharmaceuticals
Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors
Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino. - January 03, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan Pharmaceuticals has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 03, 2008 - Samaritan Pharmaceuticals
EUSA Pharma Signs Exclusive Distribution Agreement with Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus
Samaritan Pharmaceuticals, Inc. has signed an exclusive distribution agreement with EUSA Pharma to launch, promote, sell and support pain patch Rapydan in Greece and Cyprus. - January 03, 2008 - Samaritan Pharmaceuticals
New Blog Discusses the Globalization and Public Healthcare Policy Trends Affecting the Life Sciences and Health Care Industry
Larry Rothman, a lifelong participant in the health care and pharmaceutical industries, announces the launching of his blog dedicated to the latest trends and issues affecting these sectors. - January 02, 2008 - Larry Rothman's Blog
"Clinical and Economical Considerations for Iv Push Drug Delivery" by Industry Expert Richard Rosenfeld is Now Accessible on Expert411.com for Media and Professional Use
The “Clinical and Economical Considerations For IV Push Drug Delivery” technical paper – authored by Industry Expert Richard Rosenfeld, RPh, MBA, for Baxa Corporation – is now accessible at Expert411.com for media and professional reference. The paper is an overview of the historical background for IV push and a model for implementation of a successful program. - December 27, 2007 - Baxa Corporation
Mark Coflin, Global Executive Director of Business Development and Licensing for Novartis, Has Been Named Princeton Premiers Honored Member in Business
Mark Coflin, Global Executive Director of Business Development and Licensing for Novartis, has been named Princeton Premiers Honored Member in Business. Mark makes his home in East Hanover New Jersey and earned his Bachelors Degree as well as his Masters Degree in Marketing and Finance from the... - December 26, 2007 - Princeton Premier
VP, GSK and VP, AstraZeneca to Give Keynote Talks at Cancer Drugs Conference
Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. Dr. Copeland will present on mechanism-driven approaches to molecularly targeted cancer drug... - December 21, 2007 - GTCbio
Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH to Present on Regulation of T Regulatory Cells, January 28, 2008
Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH, will be the honored keynote speaker at the 6th Cytokines and Inflammation conference to be held January 28-29, 2008 in Orlando, FL. Dr. Oppenheim has done many pioneering studies of cytokines including IL-1 and... - December 21, 2007 - GTCbio
CDISC Awards STAR Recognition to Octagon Research Solutions, Inc.
Company recognized for five years of support. - December 20, 2007 - Octagon Research Solutions, Inc
Government Support Injecting Growth in Russian Pharma Industry
Rising health consciousness, growing aging population, and strong government initiatives will drive the growth of Russian Pharma Industry, leading to double-digit growth rate, says the RNCOS report. - December 17, 2007 - RNCOS
Octagon Announces Clinical Data Conversion Milestone
Company completes conversion of 100 studies to CDISC SDTM format. - December 13, 2007 - Octagon Research Solutions, Inc
Baxa Corporation Launches MedBoard™ Medication Tracking System
Baxa announces the introduction of MedBoard, the first wireless medication tracking system. MedBoard is featured at the Baxa booth (no. 2106) at the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas, December 3 – 5, 2007. With its dynamic order monitoring, MedBoard reduces waste by identifying time-sensitive orders and ensuring on-time delivery. - December 03, 2007 - Baxa Corporation
Samaritan Presented Favorable Caprospinol Data at Alzheimer's Drug Development Summit
In an in vivo 'Proof of Concept' study, Samaritan Pharmaceuticals, Inc. has confirmed Caprospinol's (SP-233) efficacy in its ability to dramatically decrease beta amyloid plaque in the brain, accompanied by a complete recovery of memory back to baseline (p=0.002), as shown in a Morris water maze task. This study confirms previously reported in vitro data and suggests Caprospinol may not only slow the progress of Alzheimer's, but may also reverse plaque-related brain injuries associated with AD. - November 27, 2007 - Samaritan Pharmaceuticals
Princeton Premier Honors Mr. Han de Min with Inclusion in the 2007-2008 Princeton Premier Registry
Princeton Premier Honors Mr. Han de Min With Inclusion in the 2007-2008 Princeton Premier Registry. Han is currently serving as a vice president for Aspen Technology and has been doing so for over a year. He currently acts as a consultant on strategic business planning. Han is a respected member... - November 27, 2007 - Princeton Premier
Thomas Waldmann, Chief, NCI to Give Keynote Talk at Immunodiagnostics & Immunomonitoring Conference
Thomas Waldmann, Chief of Metabolism & Head of Cytokine Immunology/ Immunotherapy at NCI to give keynote presentation at 2nd Immunodiagnostics & Immunomonitoring conference December 6-7, 2007 - November 22, 2007 - GTCbio
OptimizeRx Helps Patients Save on Rising Prescription Costs
Tens of thousands of patients have visited the OPTIMIZERx website (www.optimizerx.com) to save on their rising out-of-pocket costs for prescription medications since its launch in January 2007. “We are very pleased by the large number of patients who have come to OPTIMIZERx and discovered... - November 18, 2007 - OptimizeRx
New Internet Solution Enables Pharmaceutical Manufacturers to Improve Access, Adherence and Brand Loyalty
A new Internet service called OPTIMIZERx (www.optimizerx.com) will now allow pharmaceutical manufacturers to help patients better afford and comply with their prescribed brand medications. The pharmaceutical industry has come under increased pressure for the high cost of prescription medications, and major efforts are being made to steer patients towards the use of generic prescription medications. - November 18, 2007 - OptimizeRx
New Internet Site Helps Patients with Rising Prescription Drug Costs
A free, new Internet site called OPTIMIZERx (www.optimizerx.com) is now available to help the majority of patients reduce their rising costs for prescription medications. With escalating costs now being passed on to patients, many Americans are finding out the hard way that even with healthcare insurance, they are not immune to the rising cost of prescription medication. - November 15, 2007 - OptimizeRx
Octagon Announces ViewPoint(R) for Document Management
Octagon Research Solutions, Inc. announces ViewPoint(R) for document management. New solution supports the entire document lifecycle from authoring to submission. - November 14, 2007 - Octagon Research Solutions, Inc
Robert Copeland, VP, Oncology Drug Discovery, GSK to Give Keynote Talk at Cancer Drugs Conference
Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. Dr. Copeland will present on mechanism-driven approaches to molecularly targeted cancer drug... - November 11, 2007 - GTCbio
Pfizer, Novartis, and AstraZeneca to Give Featured Presentations at Oncology Biomarkers Conference
Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008. - November 11, 2007 - GTCbio
Octagon Research Solutions, Inc., Inducted in the Philadelphia 100 Hall of Fame
Octagon Research Solutions, Inc. and its Chairman and CEO, James C. Walker and Octagon Research Solutions, Inc. have been inducted in the Philadelphia 100 Hall of Fame. - November 03, 2007 - Octagon Research Solutions, Inc
Octagon Research Solutions, Inc. Ranked as One of the Fastest Growing Companies in North America on Deloitte’s 2007 Technology Fast 500
Octagon ranked number 424 on Deloitte’s 2007 Technology Fast 500. - November 02, 2007 - Octagon Research Solutions, Inc
Octagon Research Solutions, Inc. Ranked 19 in Deloitte's 2007 Greater Philadelphia Technology Fast 50
CEO and Chairman Jim Walker of Octagon Research Solutions, Inc., a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, today announced that it ranked Number 19 on Deloitte’s 2007 Greater Philadelphia Technology Fast 50. The Technology Fast 50... - November 01, 2007 - Octagon Research Solutions, Inc
NCSRT Introduces WORKS™, an Integrated Program of Products, Applications Guides, Optimization Tools, and Services
NCSRT Introduces WORKS™, an integrated program of products, applications guides, optimization tools, and services to dramatically improve downstream processing in the biopharmaceutical production environment. With the patented SmartFlow™ TFF modules and industry leading PUROSEP®... - October 30, 2007 - NCSRT, Inc.
Gary Peltz, Head of Genetics & Genomics at Roche Palo Alto to Give Keynote Talk on Computational Genetics at PK/PD Track of 3rd Modern Drug Discovery & Development Summit
Gary Peltz, Head of Genetic/Genomics at Roche to give keynote presentation at PK/PD track at 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco. - October 26, 2007 - GTCbio
Taneaba Samuel, a Pharmacy Technician, Has Been Selected for Inclusion in the 2007-2008 Princeton Premier Registry
Taneaba Samuel, a pharmacy technician, has been selected for inclusion in the 2007-2008 Princeton Premier Registry. Taneaba is currently employed by the Mental Health and Mental Retardation Authority of Harris County in Sugar Land Texas. As a pharmacy technician, Taneaba helps the elderly as well... - October 21, 2007 - Princeton Premier
Dr. Stephen K. Burley, CSO and SVP of Research at SGX Pharmaceuticals Will Give the Keynote Presentation at 3rd Modern Drug Discovery & Development Summit
Dr. Stephen K. Burley, CSO and SVP of Research at SGX Pharmaceuticals will give the Keynote presentation at GTCbio’s Drug Design & Lead Discovery conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco. - October 19, 2007 - GTCbio
Dr. David Kaslow, Vice President of Infectious Diseases and Vaccines at Merck to Give Keynote Presentation at 3rd Modern Drug Discovery & Development Summit
Dr. David Kaslow, VP of Infectious Diseases and Vaccines at Merck will give the Keynote presentation at GTCbio’s Biological Therapeutics conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 at the Hyatt Regency San Francisco Airport. - October 19, 2007 - GTCbio
AdvantaPure’s Reinforced Silicone Hose Now Offered in Custom Colors for At-a-Glance Identification
Multi-layer silicone hose, called APSM, from AdvantaPure is now available in custom colors for easy recognition. Colored APSM makes line identification quicker, as it eliminates the need to read a label. It also allows for recognition anywhere along the entire length of hose, a great advantage in situations where time is critical. Previously available only in white, the hose is used in pressure applications in the pharmaceutical, bioprocess, biomedical, chemical, food, and beverage industries. - October 17, 2007 - NewAge Industries, Inc.
Metabolic Disease Has a Greater Effect on the Health of Our Society Than Cancer
The 3rd World Summit on Metabolic Diseases explores the latest findings and treatments for Metabolic Diseases - October 15, 2007 - GTCbio
GTCbio’s 5th International Conference on Vaccines: All Things Considered
GTCbio announces it’s the 5th anniversary of its vaccine conference held annually in Washington D.C. - October 15, 2007 - GTCbio
INVEGA™ Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL® in Acutely Ill Hospitalized Patients
In a comparison study between schizophrenia treatments INVEGA™ (paliperidone) Extended-Release Tablets and SEROQUEL® (quetiapine), Invega patients saw schizophrenia symptom improvements as early as five days into therapy and continued through the end of the two-week study period. Results were presented today at the 20th Annual U.S. Psychiatric and Mental Health Congress in Orlando, Florida. - October 13, 2007 - Johnson & Johnson
Neil Bodick, COO of Chorus – Eli Lilly & Co. to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
COO of Chorus, Eli Lilly & Co. announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D). - October 13, 2007 - GTCbio
ExL to use Pulse Media’s Text Messaging Services at Upcoming Digital Pharma Conference
Exl Pharma and Pulse Media announce the use of Pulse Media's text messaging and mobile marketing services at ExL's upcoming conference, Digital Pharma - October 13, 2007 - Pulse Media Response
Dr. William Heyward on the Forefront of the Fight Against the World's Deadliest Communicable Diseases
For nearly three decades, William Heyward has been on the forefront in the fight against some of the world's deadliest communicable diseases. HIV/AIDS, Ebola, haemophilius influenzae, hepatitis B, and hepatic cancer are among the many illnesses he has focused his attention on in places as far-flung as Zaire, Alaska, South America and Thailand. Dr. Heyward has lived on the leading edge of research on the causes, effects and prevention of devastating diseases among some of the world's poorest area - October 12, 2007 - William Heyward
GTCbio’s 3rd Modern Drug Discovery and Development Summit
GTCbio announces its flagship event – the 3rd Modern Drug Discovery and Development Summit (M3D) on Nov. 28-30, 2007 in San Francisco – featuring four plenary keynote speeches from top level execs at Pfizer, Eli Lilly, Wyeth as well as Nobel Laureate Ferid Murad at UT Houston. - October 11, 2007 - GTCbio
Global Search for a Cancer Cure Drives Market for Benda Pharmaceutical’s Gene Therapy Medicine
China-AsiaStocks.com Profiles New Showcase China Stock for Investors Following Sector; Benda Pharmaceutical, Inc., Producer of Conventional and Traditional Chinese Medicines - October 11, 2007 - InvestorIdeas.com
SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
SVP and Site Head of Pfizer La Jolla announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D). - October 10, 2007 - GTCbio
Pharmaceutical Problem Solved with Conveyor Belt Technology
Smart conveyors assist pharmaceutical company control throughput of secure products. - October 08, 2007 - Automation Supplies
20 Year Sales Veteran Named ForceLogix Vice President of Sales to Drive Sales Performance Management and Sales Coaching Solutions
ForceLogix today announced the addition of Tim Hackett as its new Vice President of Worldwide Sales, with a focus to drive industry leading sales performance management and sales coaching to the marketplace. - October 03, 2007 - ForceLogix
World-Renowned Physician and HIV Researcher Joins Samaritan's Advisory Board
Samaritan announced today the appointment of James E.K. Hildreth, M.D., a world renowned physician and HIV researcher, to its Scientific Advisory Board. The work of Dr. Hildreth in HIV/AIDS dates back to 1986 and focuses on blocking HIV infection by learning how HIV gets into cells. He has published more than 80 scientific articles and holds six patents. - October 03, 2007 - Samaritan Pharmaceuticals
Injectable Therapy Services, Inc. Receives JCAHO Gold Seal of Approval
Injectable Therapy Services, Inc (ITSRx Pharmacy) a leading national provider of specialty pharmaceuticals and affiliated healthcare services, announced that it has received the Gold Seal of Approval™ from the Joint Commission on Accreditation of Healthcare Organizations (JCAHO). - October 01, 2007 - Injectable Therapy Services Pharmacy